

SteelPeak Wealth LLC cut its stake in shares of Capital Group International Core Equity ETF (NYSEARCA:CGIC) by 26.8% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 41,117 shares of the company's stock after selling 15,033 shares during the period. SteelPeak Wealth LLC owned about


[url="]Ionis Pharmaceuticals, Inc.[/url] (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has approved ZANVASTRO⢠(zilganersen)

Capital Group International Core Equity ETF offers actively managed, ex-U.S. large-cap exposure with a focus on dividend and earnings strength. CGIC is diversified by geography and sector, but its fundamental profile and risk/return metrics closely mirror the passive IXUS benchmark. Despite impressive AUM growth and a reputable management team, CGIC's two-year track record has not yet demonstrated outperformance versus value-tilted peers IVLU and DFIV.

Centaurus Financial Inc. reduced its stake in Capital Group International Core Equity ETF (NYSEARCA:CGIC) by 76.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 9,481 shares of the company's stock after selling 30,697 shares during the period. Centaurus Financial Inc.'s

Cetera Investment Advisers grew its stake in Capital Group International Core Equity ETF (NYSEARCA:CGIC) by 44.6% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 827,453 shares of the company's stock after acquiring an additional 255,218 shares during the quarter. Cetera


Confluence Wealth Services Inc. increased its stake in shares of Capital Group International Core Equity ETF (NYSEARCA:CGIC) by 1,213.7% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 155,241 shares of the company's stock after buying an additional 143,424 shares during the period.